ON-TARGETplus Non-targeting Control Pool… and 2 more items

The University of Nebraska-Lincoln, Board of Regents issued Purchase Order 4800172126 to Horizon Discovery Biosciences Ltd, a vendor based in Waterbeach, Cambridge, United Kingdom, on January 20, 2026. The contract, valued at $741, encompasses the procurement of three research reagent line items for delivery to the E119 Beadle Center at UNL's Lincoln campus. The period of performance extends from the award date of January 20, 2026, through the requested delivery date of January 26, 2026, with payment terms of net upon receipt of goods and invoice.

The contract deliverables consist of specialized research-grade small interfering ribonucleic acid (siRNA) products and control materials. Specifically, the order includes one unit of ON-TARGETplus Non-targeting Control Pool ($269), one unit of ON-TARGETplus Human RBX1 siRNA at 5 nanomoles ($236), and one unit of ON-TARGETplus Human RBX2/RNF7 siRNA at 5 nanomoles ($236). All materials are to be delivered freight prepaid on a Free on Board destination basis. The transaction is processed as tax-exempt under UNL's tax exemption status and is governed by the University's Standard Terms of Purchase.